查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433324

2023-2030 年全球全切片影像市场

Global Whole Slide Imaging Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

预计在预测期内（2023-2030 年），全球全切片影像市场将以 6.4% 的CAGR成长。该市场的成长归因于全球电脑处理能力的增强。功能强大的电脑的发展使得处理和分析 WSI 扫描器产生的大量影像成为可能。由于技术的进步，影像分析变得更加快速和精确。据美国国立卫生研究院 (gov.) 称，2023 年 7 月，病理学家、病理部门和研究科学家对全切片影像的使用有所增加。 2018 年和 2020 年进行的一项调查发现，无论是否使用传统玻片，病理学家进行初步诊断的舒适度分别从 54% 增加到 90%，从 23% 增加到 60%。这很大程度上归功于技术的进步，包括最先进的光学和机器人技术、电脑处理能力、资料传输速度、软体开发和云端储存解决方案的提高。因此，WSI 已用于远端病理学、咨询、肿瘤板、玻片存檔以及与多种免疫组织化学染色的比较。

细分市场前景

全球全切片影像市场按技术、应用和最终用户进行细分。根据技术，市场细分为扫描器、IT 基础设施和检视器影像管理系统。根据应用，市场细分为远端病理学、细胞病理学、免疫组织化学、血液病理学等。此外，根据最终用户，市场细分为学术机构、医院和医疗机构、药物研究和合约研究组织（CRO）等。细胞病理学子类别预计将占据应用领域的很大一部分市场份额。不断增加的人口基数容易罹患多种疾病。细胞病理学是一种专门的诊断程序，透过检查从组织中取出的单一细胞来确定疾病的来源和性质。

预计扫描器细分市场将在全球全切片影像市场中占据相当大的份额

在这些技术中，扫描器细分市场预计将在全球全切片影像市场中占据相当大的份额。此细分市场的成长归因于全球数位病理学需求的增加。对数位病理学解决方案的需求不断增加，远端存取幻灯片、远端病理学和协作分析只是数位病理学优势的一部分。病理学家和研究人员可以透过使用 NanoZoomer S20MD 等扫描仪从数位病理学中受益。例如，2023 年3 月，Hamamatsu Photonics 发布了新型NanoZoomer S20MD 载玻片扫描器系统(C16300-21MDEU)。NanoZoomer S20MD 载玻片扫描器系统提供卓越的影像品质和快速的吞吐量，可在15 分钟内扫描20 张载玻片。它采用与高端型号相同的像素路径设计，并包括影像撷取和检视软体。它也符合 IVDR（欧盟）、UKCA（英国）和 IvDO（瑞士）法规。

区域展望

全球全切片影像市场根据地理位置进一步细分，包括北美（美国和加拿大）、欧洲（英国、义大利、西班牙、德国、法国和欧洲其他地区）、亚太地区（印度、中国、日本、韩国和亚洲其他地区）以及世界其他地区（中东和非洲以及拉丁美洲）。其中，由于人们对全切片影像优势的认识不断提高，加上印度和中国等一些国家人口基数广泛，预计亚太地区将在全球市场中占据显着份额。以促进该地区的市场成长。

北美地区预计全球全切片影像市场复合CAGR显着成长

在所有地区中，北美地区预计在预测期内将以相当大的CAGR成长。区域增长归因于全球远端病理学和远端细胞学的发展。该研究在远距细胞学评估中成功达到高灵敏度和特异性，并强调了远距病理学在医疗保健改善中的重要性。涉及远端细胞学的远端病理学使病理学家能够远端存取和解释数位切片，从而更容易提供诊断和咨询，特别是在缺乏专业知识的领域。据MDPI 称，2023 年10 月，这项前瞻性研究分析了LungenClinic Grosshansdorf 对239 名患者进行的314 项快速远端线上细胞学评估（154 项印记细胞学检查、143 项细针穿刺细胞学检查和17项刷细胞学检查）。在透过远端细胞学进行现场评估期间，记录了时间要求，并将结果与细胞/组织学和最终诊断进行比较。结果显示，细胞学良性86例，恶性190例，不明诊断38例。排除诊断不明确的37例标本，最终诊断的敏感度为90.5%，特异度为98.5%，分类正确率为92.4%。细针穿刺对恶性肿瘤细胞学检测的敏感率为76.1%，排除37例不明原因的检体后，敏感率为92.5%。

市场参与者展望

服务于全切片影像市场的主要公司包括 Leica Microsystems GmbH、Olympus Corp. Philips International BV、NIKON CORP.、Visiopharm A/S 等。市场参与者透过各种策略（包括併购、合作、合作、融资和新产品发布），为市场成长做出了巨大贡献，以保持市场竞争力。例如，2022 年 9 月，Infinitt 与 Hamamatsu 合作，改进了与 NanoZoomers 的集成，使实验室和病理学家能够在端到端操作工作流程中审查玻片。此外，IDPS 与 LIS 的整合将使病理学家能够在数位环境中更有效率地工作。

报告涵盖：

  • 2022年市场价​​值资料分析及2030年预测。
  • 每个细分市场的年化市场收入（百万美元）。
  • 主要地理区域的国家分析。
  • 全球全切片影像市场的主要公司。根据现有资料，报告中还提供了与新产品发布相关的资讯以及相关新闻。
  • 透过确定未来强劲成长的关键细分市场来分析业务策略。
  • 市场进入和市场扩张策略分析。透过识别市场中「谁的立场」来制定竞争策略。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • 3DHISTECH Ltd.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Aiforia Technologies Oyj
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Akoya Biosciences, Inc.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 2 章：市场细分

  • 按技术分類的全球全切片影像市场
    • 扫描仪
    • IT基础架构
    • 浏览器图像管理系统
  • 按应用分類的全球全切片影像市场
    • 远端病理学
    • 细胞病理学
    • 免疫组织化学
    • 血液病理学
    • 其他（神经病理学、法医病理学）
  • 按最终用户分類的全球全切片影像市场
    • 有刷微电机
    • 无刷微电机
  • 按最终用户分類的全球全切片影像市场
    • 学术机构
    • 医院及医疗机构
    • 药物研究和合约研究组织 (CRO)
    • 其他（生物技术和製药公司以及政府卫生机构）

第 3 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 4 章：公司简介

  • CureMetrix, Inc.
  • Flagship Biosciences, Inc.
  • HAMAMATSU Group
  • Huron Digital Pathology
  • Indica Labs, Inc.
  • Leica Microsystems GmbH
  • MBF Bioscience
  • Mikroscan Technologies
  • Molecular Machines & Industries GmbH
  • NIKON CORP.
  • Olympus Corp.
  • OPAL KELLY INC.
  • OptraSCAN Inc.
  • PerkinElmer AES
  • Philips International B.V.
  • Visiopharm A/S
  • Zeiss AG
Product Code: OMR2027993

Global Whole Slide Imaging Market Size, Share & Trends Analysis Report by Technology (Scanners, IT Infrastructure, and ViewerImage Management System), by Application (Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others), and by End-User (Academic Institute, Hospitals and Healthcare Institutions, Pharmaceutical Research and Contract Research Organizations (CROs), and Others), Forecast Period (2023-2030)

The global whole slide imaging market is anticipated to grow at a CAGR of 6.4% during the forecast period (2023-2030). The market's growth is attributed to the increased computer processing power across the globe. The development of powerful computers has made it possible to process and analyze enormous images generated by WSI scanners. Image analysis has grown more rapid and precise as a result of technology. According to the National Institute of Health (gov.), in July 2023, the use of whole slide imaging has increased among pathologists, pathology departments, and research scientists. A survey conducted in 2018 and 2020 found that the comfort of pathologists to make a primary diagnosis with or without access to traditional glass slides increased from 54% to 90%, and from 23% to 60%, respectively. This is largely attributed to advancements in technology, including state-of-the-art optics and robotics, increased computer processing power, data transfer speeds, software development, and cloud storage solutions. As such, WSI has been used for telepathology, consultation, tumor boards, archiving slides, and comparisons with multiple immunohistochemical staining.

Segmental Outlook

The global whole slide imaging market is segmented on the technology, application, and end-user. Based on the technology, the market is sub-segmented into scanners, it infrastructure, and viewer image management system. Based on the application, the market is sub-segmented into telepathology, cytopathology, immunohistochemistry, hematopathology, and others. Furthermore, on the basis of end-user, the market is sub-segmented into academic institute, hospitals and healthcare institutions, pharmaceutical research and contract research organizations (CROs), and others. The cytopathology subcategory is expected to capture a significant portion of the market share within the application segment. The increasing population base prone to numerous diseases. Cytopathology is a specialized diagnostic procedure that examines individual cells removed from tissues to determine the source and nature of a disease.

The Scanners Sub-Segment is Anticipated to Hold a Considerable Share of the Global Whole Slide Imaging Market

Among the technology, the scanners sub-segment is expected to hold a considerable share of the global whole slide imaging market. The segmental growth is attributed to the increased demand for digital pathology across the globe. Increase in demand for digital pathology solutions remote access to slides, telepathology, and collaborative analysis are merely a few of the advantages of digital pathology. Pathologists and researchers can benefit from digital pathology by utilizing scanners such as the NanoZoomer S20MD. For instance, in March 2023, Hamamatsu Photonics, released the new NanoZoomer S20MD Slide scanner system (C16300-21MDEU).The NanoZoomer S20MD Slide scanner system offers excellent image quality and rapid throughput, scanning 20 slides in 15 minutes. It is designed with the same pixel pathway as the high-end model and includes image acquisition and viewing software. It is additionally compliant with IVDR (EU), UKCA (UK) and IvDO (CH) regulations.

Regional Outlook

The global whole slide imaging market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to rising awareness of the benefits of whole slide imaging, in addition to an extensive population base in some countries such as India and China, have contributed to the region's market growth.

The North America Region is Expected to Grow at a Significant CAGR in the Global Whole Slide Imaging Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the telepathology and tele-cytology development across the globe. The study's success in reaching high sensitivity and specificity rates in remote cytological evaluations emphasizes the significance of telepathology in healthcare improvement. Telepathology, that involve tele-cytology, enables pathologists to remotely access and interpret digital slides, making it easier to provide diagnosis and consultations, particularly in areas where specialist expertise is scarce. According to the MDPI, in October 2023, the prospective study analyzed 314 Rapid Remote Online Cytological Evaluations (154 imprint cytologies, 143 fine needle aspirations and 17 brush cytologies) performed on 239 patients at the LungenClinic Grosshansdorf. During on-site evaluation via tele-cytology, the time requirement was recorded and the findings were compared with the cyto-/histological and final diagnoses. The results showed that 86 cytological benign, 190 malignant and 38 unclear diagnoses were recorded. Excluding the 37 specimens with unclear diagnoses, the sensitivity rate was 90.5%, the specificity rate was 98.5% and the correct classification rate was 92.4% with regard to the final diagnosis. The sensitivity rate for the cytological detection of malignant tumors was 76.1% for fine-needle aspirations and 92.5% when excluding the 37 specimens with unclear findings.

Market Players Outlook

The major companies serving the whole slide imaging market include Leica Microsystems GmbH, Olympus Corp. Philips International B.V., NIKON CORP., Visiopharm A/S, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2022, Infinitt collaborated with Hamamatsu, offered improved integration with NanoZoomers, allowing laboratories and pathologists to review slides in an end-to-end operational workflow. Furthermore, the integration of IDPS with LIS will allow pathologists to work more efficiently in a digital environment.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global whole slide imaging market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. 3DHISTECH Ltd.
    • 1.1.1. Overview
    • 1.1.2. Financial Analysis
    • 1.1.3. SWOT Analysis
    • 1.1.4. Recent Developments
  • 3.3. Aiforia Technologies Oyj
    • 1.1.5. Overview
    • 1.1.6. Financial Analysis
    • 1.1.7. SWOT Analysis
    • 1.1.8. Recent Developments
  • 3.4. Akoya Biosciences, Inc.
    • 1.1.9. Overview
    • 1.1.10. Financial Analysis
    • 1.1.11. SWOT Analysis
    • 1.1.12. Recent Developments
  • 1.2. Key Strategy Analysis

2. Market Segmentation

  • 2.1. Global Whole Slide Imaging Market by Technology
    • 2.1.1. Scanners
    • 2.1.2. IT Infrastructure
    • 2.1.3. ViewerImage Management System
  • 2.2. Global Whole Slide Imaging Market by Application
    • 2.2.1. Telepathology
    • 2.2.2. Cytopathology
    • 2.2.3. Immunohistochemistry
    • 2.2.4. Hematopathology
    • 2.2.5. Others(Neuropathology, and Forensic Pathology)
  • 2.3. Global Whole Slide Imaging Market by End User
    • 2.3.1. Brushed Micromotor
    • 2.3.2. Brushless Micromotor
  • 2.4. Global Whole Slide Imaging Market by End-User
    • 2.4.1. Academic Institute
    • 2.4.2. Hospitals and Healthcare Institutions
    • 2.4.3. Pharmaceutical Research and Contract Research Organizations (CROs)
    • 2.4.4. Others(Biotechnology and Pharmaceutical Companies, and Government Health Agencies)

3. Regional Analysis

  • 3.1. North America
    • 3.1.1. United States
    • 3.1.2. Canada
  • 3.2. Europe
    • 3.2.1. UK
    • 3.2.2. Germany
    • 3.2.3. Italy
    • 3.2.4. Spain
    • 3.2.5. France
    • 3.2.6. Rest of Europe
  • 3.3. Asia-Pacific
    • 3.3.1. China
    • 3.3.2. India
    • 3.3.3. Japan
    • 3.3.4. South Korea
    • 3.3.5. Rest of Asia-Pacific
  • 3.4. Rest of the World

4. Company Profiles

  • 4.1. CureMetrix, Inc.
  • 4.2. Flagship Biosciences, Inc.
  • 4.3. HAMAMATSU Group
  • 4.4. Huron Digital Pathology
  • 4.5. Indica Labs, Inc.
  • 4.6. Leica Microsystems GmbH
  • 4.7. MBF Bioscience
  • 4.8. Mikroscan Technologies
  • 4.9. Molecular Machines & Industries GmbH
  • 4.10. NIKON CORP.
  • 4.11. Olympus Corp.
  • 4.12. OPAL KELLY INC.
  • 4.13. OptraSCAN Inc.
  • 4.14. PerkinElmer AES
  • 4.15. Philips International B.V.
  • 4.16. Visiopharm A/S
  • 4.17. Zeiss AG

LIST OF TABLES

  • 1. GLOBAL WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 2. GLOBAL WHOLE SLIDE IMAGING BY SCANNERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL WHOLE SLIDE IMAGING BY IT INFRASTRUCTURE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL WHOLE SLIDE IMAGING BY VIEWERIMAGE MANAGEMENT SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 6. GLOBAL WHOLE SLIDE IMAGING IN TELEPATHOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL WHOLE SLIDE IMAGING IN CYTOPATHOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL WHOLE SLIDE IMAGING IN IMMUNOHISTOCHEMISTRY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL WHOLE SLIDE IMAGING IN HEMATOPATHOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL WHOLE SLIDE IMAGING IN OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 12. GLOBAL WHOLE SLIDE IMAGING FOR ACADEMIC INSTITUTE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL WHOLE SLIDE IMAGING FOR HOSPITALS AND HEALTHCARE INSTITUTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL WHOLE SLIDE IMAGING FOR PHARMACEUTICAL RESEARCH AND CONTRACT RESEARCH ORGANIZATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL WHOLE SLIDE IMAGING FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. GLOBAL WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION,2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 21. EUROPEAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 22. EUROPEAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 23. EUROPEAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION , 2022-2030 ($ MILLION) EUROPEAN WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 24. ASIA- PACIFIC WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 26. ASIA- PACIFIC WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION , 2022-2030 ($ MILLION)
  • 27. ASIA- PACIFIC WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY APPLICATION ,2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD WHOLE SLIDE IMAGING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL WHOLE SLIDE IMAGING MARKET SHARE BY TECHNOLOGY, 2022 VS 2030 (%)
  • 2. GLOBAL WHOLE SLIDE IMAGING BY SCANNERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL WHOLE SLIDE IMAGING BY IT INFRASTRUCTURE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL WHOLE SLIDE IMAGING BY VIEWERIMAGE MANAGEMENT SYSTEM MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL WHOLE SLIDE IMAGING MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 6. GLOBAL WHOLE SLIDE IMAGING IN TELEPATHOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL WHOLE SLIDE IMAGING IN CYTOPATHOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL WHOLE SLIDE IMAGING IN IMMUNOHISTOCHEMISTRY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL WHOLE SLIDE IMAGING IN HEMATOPATHOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL WHOLE SLIDE IMAGING IN OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL WHOLE SLIDE IMAGING MARKET SHARE BY END USER, 2022 VS 2030 (%)
  • 12. GLOBAL WHOLE SLIDE IMAGING FOR ACADEMIC INSTITUTE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL WHOLE SLIDE IMAGING FOR HOSPITALS AND HEALTHCARE INSTITUTIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL WHOLE SLIDE IMAGING FOR PHARMACEUTICAL RESEARCH AND CONTRACT RESEARCH ORGANIZATIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL WHOLE SLIDE IMAGING FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL WHOLE SLIDE IMAGING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. US WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. CANADA WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. UK WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. FRANCE WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. GERMANY WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. ITALY WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. SPAIN WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF EUROPE WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. INDIA WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. CHINA WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. JAPAN WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. SOUTH KOREA WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. REST OF ASIA-PACIFIC WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD WHOLE SLIDE IMAGING MARKET SIZE, 2022-2030 ($ MILLION)